331 related articles for article (PubMed ID: 28207938)
1. Comparison of clinical and pathological features of lung lesions of systemic IgG4-related disease and idiopathic multicentric Castleman's disease.
Terasaki Y; Ikushima S; Matsui S; Hebisawa A; Ichimura Y; Izumi S; Ujita M; Arita M; Tomii K; Komase Y; Owan I; Kawamura T; Matsuzawa Y; Murakami M; Ishimoto H; Kimura H; Bando M; Nishimoto N; Kawabata Y; Fukuda Y; Ogura T;
Histopathology; 2017 Jun; 70(7):1114-1124. PubMed ID: 28207938
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary Manifestations of Plasma Cell Type Idiopathic Multicentric Castleman Disease: A Clinicopathological Study in Comparison with IgG4-Related Disease.
Nishimura MF; Igawa T; Gion Y; Tomita S; Inoue D; Izumozaki A; Ubara Y; Nishimura Y; Yoshino T; Sato Y
J Pers Med; 2020 Dec; 10(4):. PubMed ID: 33321725
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin G4-related disease and idiopathic multicentric Castleman's disease: confusable immune-mediated disorders.
Sasaki T; Akiyama M; Kaneko Y; Takeuchi T
Rheumatology (Oxford); 2022 Feb; 61(2):490-501. PubMed ID: 34363463
[TBL] [Abstract][Full Text] [Related]
4. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease.
Sato Y; Kojima M; Takata K; Morito T; Asaoku H; Takeuchi T; Mizobuchi K; Fujihara M; Kuraoka K; Nakai T; Ichimura K; Tanaka T; Tamura M; Nishikawa Y; Yoshino T
Mod Pathol; 2009 Apr; 22(4):589-99. PubMed ID: 19270642
[TBL] [Abstract][Full Text] [Related]
5. Investigation of IgG4-positive cells in idiopathic multicentric Castleman disease and validation of the 2020 exclusion criteria for IgG4-related disease.
Nishikori A; Nishimura MF; Nishimura Y; Notohara K; Satou A; Moriyama M; Nakamura S; Sato Y
Pathol Int; 2022 Jan; 72(1):43-52. PubMed ID: 34762752
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic multicentric castleman's disease mimicking immunoglobulin G4-related disease responding well to Bortezomib: a case report.
Peng Q; Wu F; Shi Y; Wang J; Zhai Z; Wang Z
BMC Nephrol; 2023 Oct; 24(1):290. PubMed ID: 37784011
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic multicentric Castleman's disease: a clinicopathologic study in comparison with IgG4-related disease.
Otani K; Inoue D; Fujikura K; Komori T; Abe-Suzuki S; Tajiri T; Itoh T; Zen Y
Oncotarget; 2018 Jan; 9(6):6691-6706. PubMed ID: 29467920
[TBL] [Abstract][Full Text] [Related]
8. Overlap of IgG4-related Disease and Multicentric Castleman's Disease in a Patient with Skin Lesions.
Mochizuki H; Kato M; Higuchi T; Koyamada R; Arai S; Okada S; Eto H
Intern Med; 2017; 56(9):1095-1099. PubMed ID: 28458319
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of a concurrent condition of IgG4-RD and Castleman's disease.
Zhang X; Zhang P; Peng L; Fei Y; Zhang W; Feng R; Zhang W
Clin Rheumatol; 2018 Dec; 37(12):3387-3395. PubMed ID: 29948354
[TBL] [Abstract][Full Text] [Related]
10. Utility of renal biopsy in differentiating idiopathic multicentric Castleman disease from IgG4-related disease.
Kawanishi M; Kamei F; Sonoda H; Oba M; Fukunaga S; Egawa M; Koyama T; Sato Y; Tanabe K; Ito T
CEN Case Rep; 2023 May; 12(2):242-248. PubMed ID: 36414812
[TBL] [Abstract][Full Text] [Related]
11. The clinicopathological comparison among nodal cases of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
Kurose N; Futatsuya C; Mizutani KI; Kumagai M; Shioya A; Guo X; Aikawa A; Nakada S; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Kojima M; Nakamura S; Yamada S
Hum Pathol; 2018 Jul; 77():130-138. PubMed ID: 29684500
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous multicentric Castleman's disease mimicking IgG4-related disease.
Takeuchi M; Sato Y; Takata K; Kobayashi K; Ohno K; Iwaki N; Orita Y; Yoshino T
Pathol Res Pract; 2012 Dec; 208(12):746-9. PubMed ID: 23102767
[TBL] [Abstract][Full Text] [Related]
13. [Pathological significance of plasma cell infiltration in diagnosing lymph node diseases].
Hu H; Jiang YJ; Xu L; Yin LJ; Liu XF; Yin SY; Xu JJ; He MX
Zhonghua Bing Li Xue Za Zhi; 2023 Jul; 52(7):702-709. PubMed ID: 37408401
[No Abstract] [Full Text] [Related]
14. Diagnostic challenges of the idiopathic plasmacytic lymphadenopathy (IPL) subtype of idiopathic multicentric Castleman disease (iMCD): Factors to differentiate from IgG4-related disease.
Nishikori A; Nishimura MF; Fajgenbaum DC; Nishimura Y; Maehama K; Haratake T; Tabata T; Kawano M; Nakamura N; Momose S; Sumiyoshi R; Koga T; Yamamoto H; van Rhee F; Kawakami A; Sato Y
J Clin Pathol; 2024 Feb; ():. PubMed ID: 38378248
[TBL] [Abstract][Full Text] [Related]
15. Comparison of IgG4-Related Lymphadenopathy and Multicentric Castleman's Disease: a Retrospective Study.
Sun C; Xu G; Lin J
Clin Lab; 2018 Oct; 64(10):1671-1678. PubMed ID: 30336525
[TBL] [Abstract][Full Text] [Related]
16. Concordance between transbronchial lung cryobiopsy and surgical lung biopsy in patients with idiopathic multicentric Castleman disease: A report of four cases.
Otoshi R; Kitamura H; Baba T; Muraoka T; Sekine A; Takemura T; Okudela K; Sawazumi T; Ogura T
Respir Investig; 2024 Jan; 62(1):1-8. PubMed ID: 37925882
[TBL] [Abstract][Full Text] [Related]
17. Abundant immunoglobulin (Ig)G4-positive plasma cells in interstitial pneumonia without extrathoracic lesions of IgG4-related disease: is this finding specific to IgG4-related lung disease?
Ikeda S; Sekine A; Baba T; Okudela K; Iwasawa T; Sakai F; Notohara K; Ohashi K; Takemura T; Ogura T
Histopathology; 2017 Jan; 70(2):242-252. PubMed ID: 27485309
[TBL] [Abstract][Full Text] [Related]
18. IL-6 expression helps distinguish Castleman's disease from IgG4-related disease in the lung.
Kinugawa Y; Uehara T; Iwaya M; Asaka S; Kobayashi S; Nakajima T; Komatsu M; Yasuo M; Yamamoto H; Ota H
BMC Pulm Med; 2021 Jul; 21(1):219. PubMed ID: 34246246
[TBL] [Abstract][Full Text] [Related]
19. [Idiopathic multicentric Castleman's disease].
Vasilyev VI; Palshina SG; Pavlovskaya AI; Kokosadze NV; Chaltsev BD; Shornikova LA
Ter Arkh; 2020 Jun; 92(5):78-84. PubMed ID: 32598779
[TBL] [Abstract][Full Text] [Related]
20. Assessment of pathologically diagnosed patients with Castleman's disease associated with diffuse parenchymal lung involvement using the diagnostic criteria for IgG4-related disease.
Ogoshi T; Kido T; Yatera K; Oda K; Kawanami T; Ishimoto H; Sakamoto N; Sano A; Yoshii C; Shimajiri S; Mukae H
Lung; 2013 Dec; 191(6):575-83. PubMed ID: 23942842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
